Haepatitis B

Product Details:

It is used for the treatment of hepatitis Cvirus (HCV) infection. It has been marketed since 2013. Compared to previous treatments, sofosbuvir-based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy. Sofosbuvir allows most patients to be treated successfully without the use of peginterferon,an injectable drug with severe side effects^. that is a key component of older drug combinations for the treatment of HCV.

Product Details:

It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.